RADIOTHERAPY

This study is testing whether combining a drug called TAS-102 with radiation therapy is safe and effective for elderly patients with locally advanced esophageal cancer. The goal is to control the cancer and improve survival rates. The research will first find the safest dose of t…

This study is testing if adding a special, condensed form of radiation therapy to a new immunotherapy drug and standard chemotherapy works better for people with advanced lung cancer. The goal is to see if this three-part combination can shrink tumors more effectively and help pa…

This study is testing a two-part treatment given before surgery for stage II-III rectal cancer. First, patients receive a short, focused course of radiation designed to spare certain lymph nodes. Then, they receive an immunotherapy drug (a PD-1 inhibitor) to help the immune syste…

This study is testing whether a new motion monitoring system can help deliver radiation therapy more accurately to cancers in the chest and upper abdomen. These areas move with breathing, making precise treatment challenging. The research will involve 20 patients receiving standa…

This study aims to find out if radiation therapy after surgery helps prevent a rare and aggressive adrenal gland cancer from coming back. It will enroll 58 patients who have had surgery and are at high risk of recurrence. Participants will be randomly assigned to either receive r…

This large national study aims to see if adding immunotherapy drugs to the standard pre-surgery treatment (chemotherapy and radiation) works better for people with high-risk rectal cancer. It will also compare two different lengths of radiation treatment. The goal is to shrink tu…

This study is for people with advanced non-small cell lung cancer that has spread to more than five places in the body. It will test if adding a strong, focused radiation treatment to the main lung tumor, on top of standard drug therapy, helps patients live longer and keeps the c…

This study is testing if a very low dose of radiation can make tumors sensitive again to immunotherapy drugs in patients with advanced esophageal cancer that has stopped responding to standard treatment. About 32 adults who have progressed after first-line chemo-immunotherapy wil…

This study is testing if adding a dietary supplement called β-hydroxybutyrate (a type of ketone) to a standard combination of short radiation, chemotherapy, and immunotherapy can improve results for people with locally advanced rectal cancer. It will involve 48 adults who have no…

This study is testing a combination treatment for people with advanced solid tumors that have spread or returned. It combines a pill made from a natural fungus compound (PRaG-1) with targeted radiation, immune-boosting injections, and standard immunotherapy drugs. The main goal i…

This study aims to see if listening to calming music during a patient's first radiation therapy session can make the experience easier. Researchers will compare 72 cancer patients receiving standard care to those who also get a 15-20 minute music therapy session. They will measur…

This study aims to find out if using video calls is better than phone calls for educating breast cancer patients before they start radiation therapy. Researchers want to see if seeing their care team on video helps reduce patients' fears and concerns about the treatment more effe…

This study aims to test if a simple electrical device can accurately measure fluid buildup (swelling) in the arms or legs of cancer patients. It will involve 46 patients in Denmark who have swelling after chemotherapy or radiation. Researchers will compare the device's readings a…

This study aims to find out if using MRI scans, instead of or alongside standard CT scans, can help doctors plan and adjust radiotherapy for cancer more precisely. It will involve up to 165 people, including healthy volunteers and patients with cancers like brain, stomach, and pa…